skip to main content
Refinado por: Base de dados/Biblioteca: EBSCO_MEDLINE Complete(医学期刊全文数据库) remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
POSA74 Accounting for Population Heterogeneity Over-Time in Estimating Costs and Outcomes in Cohort-Based Health-Economic Evaluations
Material Type:
Artigo
Adicionar ao Meu Espaço

POSA74 Accounting for Population Heterogeneity Over-Time in Estimating Costs and Outcomes in Cohort-Based Health-Economic Evaluations

Felizzi, F ; Manevy, F ; Di Maio, D

Value in health, 2022-01, Vol.25 (1), p.S47-S48 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

2
Potential non-drug cost differences associated with the use of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) in the treatment of HER2-positive early breast cancer patients in Western Europe and the United States
Material Type:
Artigo
Adicionar ao Meu Espaço

Potential non-drug cost differences associated with the use of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) in the treatment of HER2-positive early breast cancer patients in Western Europe and the United States

Manevy, Federico ; Filkauskas, Gabriele ; Levy, Pierre ; Fredriksson, Judy ; Sussell, Jesse

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.544-544 [Periódico revisado por pares]

Texto completo disponível

3
Genetic structure characterization of Chileans reflects historical immigration patterns
Material Type:
Artigo
Adicionar ao Meu Espaço

Genetic structure characterization of Chileans reflects historical immigration patterns

Eyheramendy, Susana ; Martinez, Felipe I ; Manevy, Federico ; Vial, Cecilia ; Repetto, Gabriela M

Nature communications, 2015-03, Vol.6 (1), p.6472-6472, Article 6472 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

4
White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example
Material Type:
Artigo
Adicionar ao Meu Espaço

White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example

Jackisch, Christian ; Manevy, Federico ; Frank, Suzanne ; Roberts, Nicki ; Shafrin, Jason

Advances in therapy, 2022-02, Vol.39 (2), p.833-844 [Periódico revisado por pares]

Cheshire: Springer Healthcare

Texto completo disponível

5
POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer (HER2+ BC) Patients in Italy: A Budget Impact Analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer (HER2+ BC) Patients in Italy: A Budget Impact Analysis

Bellone, M ; Pradelli, L ; Sanfilippo, A ; Caputo, A ; Manevy, F ; Zerilli, A

Value in health, 2022-01, Vol.25 (1), p.S109-S109 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até

Buscando em bases de dados remotas. Favor aguardar.